CTA
AGN

Chesley Taft & Associates’s Allergan Inc AGN Stock Holding History

Chesley Taft & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,171
Closed -$4.08M – 248
2014
Q4 		$4.08M Sell
19,171
-65
-0.3% -$12.9K 0.41% 76
2014
Q3 		$3.43M Sell
19,236
-725
-4% -$120K 0.36% 80
2014
Q2 		$3.38M Sell
19,961
-3,036
-13% -$473K 0.35% 85
2014
Q1 		$2.85M Buy
22,997
+2,155
+10% +$262K 0.31% 91
2013
Q4 		$2.31M Buy
20,842
+385
+2% +$36.8K 0.23% 111
2013
Q3 		$1.85M Buy
20,457
+68
+0.3% +$6.1K 0.2% 118
2013
Q2 		$1.72M Buy
+20,389
New +$2.12M 0.2% 114

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Chesley Taft & Associates's AGN Position: Q1 2015 in Review

Chesley Taft & Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 19,171 shares — an estimated $4.08M sold.

Chesley Taft & Associates first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.08M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Chesley Taft & Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Chesley Taft & Associates sold 19,171 Allergan Inc shares in Q1 2015, an estimated $4.08M.
  • Chesley Taft & Associates first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Chesley Taft & Associates's Allergan Inc position peaked at $4.08M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Chesley Taft & Associates's 13F filing for Q1 2015, filed 9 Apr 2015.